Search

The study objective was to determine whether N retention was improved with supplemental Zn above NRC concentrations with or without ractopamine hydrochloride inclusion. Angus crossbred steers (n = 32, 485 ± 26 kg BW) with Genemax gain scores of 4 or 5 were utilized in a 2 × 2 factorial arrangement (8 steers/treatment). Steers were blocked by BW to a finishing diet with 1 of 2 mineral supplementation strategies (ZNTRT), no supplemental Zn (analyzed 32 mg Zn/kg DM; CON) or supranutritional Zn (CON + 60 ppm ZnSO4 + 60 ppm Zn-amino acid complex; analyzed 145 mg Zn/kg DM; SUPZN), fed 56 days in pens equipped with GrowSafe bunks and assigned to β-agonist (BA) supplementation strategies of 0 (NON) or 300 mg steer−1 d−1 ractopamine hydrochloride (RAC) fed the last 30 d before harvest. Initial 56-d ADG was not affected by ZNTRT (P = 0.66), but DMI was greater in CON vs. SUPZN (P < 0.01). On day 56 (day 1 of BA supplementation), steers (4 groups; 8 steers/group; 2 steers/ treatment) were moved to metabolism crates and adapted for 10 d, followed by 5 d of total fecal and urine collection. Total retention of Zn, Mn, Fe, Cu, and N were calculated. Data were analyzed as a 2 × 2 factorial arrangement, with group as a fixed effect and the 3-way interaction of ZNTRT × BA × group as random. No interactions between ZNTRT and BA were noted for any data (P ≥ 0.19). Collection DMI did not differ among treatments (P ≥ 0.23); however, Zn intake was lesser in CON vs. SUPZN (P < 0.01). Fecal and urinary Zn excretion and Zn and Mn retention were lesser in CON vs. SUPZN (P ≤ 0.03); however, Zn retention was not different between NON and RAC (P = 0.43). Retention of Cu and Fe was unaffected by strategies (P ≥ 0.49). Urine output and urine N excretion were greater in NON vs. RAC (P ≤ 0.05). Nitrogen retention (as percent of N intake) was lesser (P = 0.05) in CON (40.0%) vs. SUPZN (44.3%) and lesser (P = 0.02) in NON (39.5%) vs. RAC (44.8%). Zinc and N retention were found to be positively correlated (r = 0.46, P < 0.01). Average daily gain and G:F across the 86-d trial were lesser in NON vs. RAC (P < 0.03). Overall, SUPZN appears to improve N retention, suggesting that increasing dietary Zn may be important for cattle growth beyond that induced by ractopamine hydrochloride. [ABSTRACT FROM AUTHOR]

To assess effects of a novel rumen-protected folic acid (RPFA) supplement, 180 Angus-cross steers (292 ± 18 kg) were blocked by body weight to pens and randomly assigned to dietary treatments (n = 6 pens/treatment): target intake of 0 (CON), 30 (RPFA-30), 60 (RPFA-60), 90 (RPFA-90), 120 (RPFA-120), or 150 (RPFA-150) mg RPFA·steer-1·d-1. Steers were weighed on d -1, 0, 55, 56 (end of growing), 86, 87, 181, and 182. Liver and blood were collected (two steers/pen) before trial initiation and at the end of growing and finishing. Data were analyzed as a randomized complete block design using ProcMixed of SAS (fixed effects of treatment and block; experimental unit of pen). Liver abscess scores were analyzed using ProcGenmod of SAS. Contrast statements evaluated polynomial effects of RPFA and compared CON vs. RPFA-30. At end of growing, RPFA linearly increased plasma folic acid (P < 0.01) and linearly decreased plasma glucose (P = 0.01). Liver folic acid concentrations at end of growing were greatest for CON, RPFA-90, and RPFA-120 (cubic P = 0.01), and growing period (d 0 to 56) average daily gain and gain:feed were greatest for CON and RPFA-120 (cubic P ≤ 0.03). At end of finishing, RPFA linearly increased plasma folic acid concentrations (P < 0.01), and liver folic acid concentrations were lesser for CON vs. RPFA-30 (P = 0.04). Severe liver abscess percentage tended to be greater for CON vs. RPFA-30 (P = 0.09), while dressing percent was lesser for CON vs. RPFA-30 (P = 0.04). Overall (d 0 to 182) carcass-adjusted gain:feed tended to be greater for CON vs. RPFA-30 (P = 0.09). Although RPFA increased plasma folic acid concentrations throughout the study, feedlot performance was not improved, possibly due to low vitamin B12 status (plasma < 200 pg/mL) of steers, regardless of treatment. [ABSTRACT FROM AUTHOR]

A 169-d study utilizing 208 Angus-cross heifers (291 ± 23 kg; 4 sources) in a 2×2 factorial examined the effects of implant strategy and Zn supplementation on growth and mineral status of heifers. Factors included 2 implant (Merck Animal Health, Madison, NJ) strategies: extended-release Revalor-XH on d 0 (REV-XH; 20 mg estradiol+200 mg trenbolone acetate) or Revalor-200 on d 0 and 91 (REV-200; 20 mg estradiol+200 mg trenbolone acetate) and 2 supplemental Zn (mg/kg dry matter [DM]; ZnSO4) strategies: national (30; NRC) or industry (100; IND) recommendations. Heifers were blocked by weight within source (n = 5 or 6 heifers/pen; 9 pens/treatment), received a corn silage-based diet (d 0-56), then transitioned to a corn-based diet fed via concrete bunks. Data were analyzed in Proc Mixed of SAS; fixed effects of implant (IMP), Zn, interaction, and source with the repeated effect of time for average daily gain (ADG) and liver mineral. Initial weight served as a covariate for performance and carcass data. Revalor-200 had greater ADG from d 0-28 and 91-120, while REV-XH peaked during d 56-91 (IMP × time; P = 0.02), corresponding to likely periods of greatest hormone payout from each implant. Liver Mn concentrations decreased on d 14 regardless of implant while d 105 and 164 concentrations were lesser for REV-200 (IMP × time; P = 0.02). Hot carcass weight, DM intake, carcass-adjusted ADG and feed efficiency were not different between IMP strategies (P = 0.18). Steers fed IND tended to be heavier on d 91 (P = 0.06) and were heavier on d 120 (P = 0.05) than NRC; however, final BW did not differ due to Zn (P = 0.37). The similar performance between implant strategies and superior performance during peak hormone payout by heifers supplemented IND vs. NRC suggests increased Zn may support rapid growth. [ABSTRACT FROM AUTHOR]